Clinical Trials Search Results
Results 1-10 of 567 for your search
Show Search Criteria
Your Search Criteria
Category |
Your Selection |
|---|---|
| Keywords/Phrases: | "colorectal cancer" |
Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1189 locations
Age: 18 years and over
Gender: Male or Female
Location: 1189 locations
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 877 locations
Age: 18 years and over
Gender: Male or Female
Location: 877 locations
Combination Chemotherapy with or without Atezolizumab in Treating Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 844 locations
Age: 18 years and over
Gender: Male or Female
Location: 844 locations
Combination Chemotherapy, Bevacizumab, and / or Atezolizumab in Treating Patients with Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 355 locations
Age: 18 years and over
Gender: Male or Female
Location: 355 locations
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer, SOLARIS Trial
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 110 locations
Age: 18 years and over
Gender: Male or Female
Location: 110 locations
Phase 1 / 2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Active
Age: 12 years and over
Gender: Male or Female
Location: 31 locations
Age: 12 years and over
Gender: Male or Female
Location: 31 locations
Savolitinib in Treating Participants with MET Amplified Metastatic or Unresectable Colorectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1 / 2 / 3 (Trk A / B / C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 26 locations
Age: 18 years and over
Gender: Male or Female
Location: 26 locations
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Nirogacestat for Adults With Desmoid Tumor / Aggressive Fibromatosis (DT / AF)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 22 locations
Age: 18 years and over
Gender: Male or Female
Location: 22 locations